tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN

Compare Basilea Pharmaceutica (BSLN) vs. Competitors

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Basilea Pharmaceutica
CHF54.10
CHF674.83M
9.05
31.31%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.37
CHF136.47M
-2.01
-32.78%
0 Buy
1 Hold
0 Sell
Hold
Idorsia Ltd
CHF3.74
CHF922.59M
-5.60
418.70%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kuros Biosciences
CHF28.16
CHF1.02B
-169.14
18.61%
1 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF27.85
CHF608.44M
23.25
202.06%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF13.88
CHF194.64M
-2.71
12.66%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:BSLN
Basilea Pharmaceutica
54.10
13.55
33.42%
CH:MOLN
Molecular Partners AG
3.26
-1.84
-36.08%
CH:IDIA
Idorsia Ltd
3.75
2.98
392.12%
CH:KURN
Kuros Biosciences
27.40
4.65
20.44%
CH:NWRN
Newron Pharmaceuticals SpA
27.85
18.73
205.37%
CH:SANN
Santhera Pharmaceuticals Holding
13.88
-0.12
-0.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts